Eric Toone

Eric Toone received his doctoral degree in Chemistry from the University of Toronto in 1988 and completed post-doctoral studies with Professor George Whitesides at Harvard University. He began his independent career at Duke in 1990, and retired from Duke in 2017 as Professor of Chemistry and Professor of Biochemistry.

During his academic career Dr. Toone authored nearly 300 original papers, reviews, book chapters and abstracts in physical organic and biophysical chemistry. He is also listed as an inventor on more than 30 patents in a range of biomedical fields and is a scientific founder of three research-based pharmaceutical companies, including Aerie Pharmaceuticals, a publicly-traded ophthalmology (glaucoma) company.

From 2009 to 2012 Dr. Toone was detailed to the US Department of Energy’s Advanced Research Projects Agency – Energy (ARPA-E). During that time, he served as Program Director and Deputy Director for Technology before leading the Agency in 2012. Dr. Toone returned to Duke in 2013 as Vice Provost and Director of the Duke University Innovation and Entrepreneurship Initiative, an initiative designed to foster entrepreneurship across the entire university community.